ALLMedicine™ Prostatitis Center

Jan 22nd, 2021 - To validate the efficacy and safety of Ningmitai capsule (NMT) in the patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). We conducted a multicenter, randomized, double-blind, placebo-controlled trial in 120 men with CP/CPPS ...

Jan 19th, 2021 - The aim of the present study was to investigate the effects of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) on bladder function and pathophysiology. To create a model for CPPS, rats were intraprostatically injected with zymosan or sa...

Jan 16th, 2021 - To perform a placebo-controlled trial to evaluate the efficacy and safety of Serenoa repens extract (SRE) for the treatment of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). We conducted a double-blind, randomized, placebo-controlled,...

Jan 14th, 2021 - To evaluate the efficacy of Lactobacillus paracasei CNCM I-1572 (L. casei DG®) in both prevention of symptomatic recurrences and improvement of quality of life in patients with chronic bacterial prostatitis (CBP). Patients with CBP attending a sin...

Jan 7th, 2021 - Chronic prostatitis (CP) is a common health condition in men. Albeight obvious, a relationship between microbial induced prostatic inflammation and sexual function has not been as thoroughly investigated. Aiming to investigate possible association...

Jan 22nd, 2021 - To validate the efficacy and safety of Ningmitai capsule (NMT) in the patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). We conducted a multicenter, randomized, double-blind, placebo-controlled trial in 120 men with CP/CPPS ...

Jan 19th, 2021 - Levofloxacin tablets are fluoroquinolone antibacterial indicated in adults (18 years of age and older) with infections caused by designated, susceptible bacteria and in pediatric patients where indicated ( 1, 12.4). • Pneumonia: Nosocomial ( 1.1) ...

Jan 19th, 2021 - Ciprofloxacin tablet is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with the following infections caused by designated, susceptible bacteria and in pediatric patients where indicated: Skin and Skin Structure Inf...

Jan 19th, 2021 - Levofloxacin tablets are fluoroquinolone antibacterial indicated in adults (18 years of age and older) with infections caused by designated, susceptible bacteria and in pediatric patients where indicated ( 1, 12.4). • Pneumonia: Nosocomial ( 1.1) ...

Jan 19th, 2021 - The aim of the present study was to investigate the effects of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) on bladder function and pathophysiology. To create a model for CPPS, rats were intraprostatically injected with zymosan or sa...

May 1st, 2016 - The incidence of true urinary tract infection (UTI) in adult males younger than 50 years is low (approximately 5-8 per year per 10,000), with adult females being 30 times more likely than males to develop a UTI. The incidence of UTI in males appro...

May 1st, 2016 - The incidence of true urinary tract infection (UTI) in adult males younger than 50 years is low (approximately 5-8 per year per 10,000), with adult females being 30 times more likely than males to develop a UTI. The incidence of UTI in males appro...

Dec 27th, 2015 - What Is Causing the Chest Pain? A 67-year-old man presents with severe chest pain radiating down both his arms. He has been in good health until the past 2 months, when he was diagnosed with and treated for gastroesophageal reflux and, more recent...

Oct 9th, 2015 - SAN DIEGO – Oral fosfomycin, a drug used for more than 4 decades to treat urinary tract infections in women, has gained a new life as a promising treatment for chronic prostatitis. In the largest patient series reported to date, a 6-week course of.

Sep 21st, 2015 - SAN DIEGO — High cure rates can be achieved with fosfomycin in patients with chronic prostatitis — many of whom are resistant to the current first-line treatment of fluoroquinolones — according to results from a new study. "For us, it's an alterna...